What is a stock summary page? Click here for an overview.
Business Description
Alligator Bioscience AB
ISIN : SE0024173637
Compare
Compare
Traded in other countries / regions
ATORX.Sweden7AL0.Germany0RK9.UK IPO Date
2016-11-30Description
Alligator Bioscience AB is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs focused on the CD40 receptor. Its drug candidate mitazalimab, is currently in preparation for Phase 3 development, and has previously presented unprecedented survival data at 18-months follow up in first-line metastatic pancreatic cancer patients in the Phase 2 trial OPTIMIZE-1.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.48 | |||||
| Equity-to-Asset | -1.25 | |||||
| Debt-to-Equity | -0.33 | |||||
| Debt-to-EBITDA | -0.26 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -24.6 | |||||
| Beneish M-Score | -4.47 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -3.5 | |||||
| 3-Year EBITDA Growth Rate | 36.5 | |||||
| 3-Year EPS without NRI Growth Rate | 34.9 | |||||
| 3-Year FCF Growth Rate | 30.4 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 48.82 | |||||
| 9-Day RSI | 35.28 | |||||
| 14-Day RSI | 38.38 | |||||
| 3-1 Month Momentum % | -51.94 | |||||
| 6-1 Month Momentum % | -90.02 | |||||
| 12-1 Month Momentum % | -87.92 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.35 | |||||
| Quick Ratio | 0.35 | |||||
| Cash Ratio | 0.32 | |||||
| Days Sales Outstanding | 2.03 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -27.8 | |||||
| Shareholder Yield % | -106.12 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -399.9 | |||||
| Net Margin % | -404.89 | |||||
| FCF Margin % | -367.73 | |||||
| ROA % | -223.65 | |||||
| ROIC % | -135.89 | |||||
| 3-Year ROIIC % | -30.65 | |||||
| ROC (Joel Greenblatt) % | -1519.5 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.84 | |||||
| EV-to-EBIT | -0.34 | |||||
| EV-to-EBITDA | -0.44 | |||||
| EV-to-Revenue | 1.26 | |||||
| EV-to-FCF | -0.34 | |||||
| Price-to-GF-Value | 0.13 | |||||
| Earnings Yield (Greenblatt) % | -294.12 | |||||
| FCF Yield % | -227.8 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Alligator Bioscience AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 57.767 | ||
| EPS (TTM) (kr) | -27.903 | ||
| Beta | 2.34 | ||
| 3-Year Sharpe Ratio | 0.34 | ||
| 3-Year Sortino Ratio | 1.05 | ||
| Volatility % | 371.7 | ||
| 14-Day RSI | 38.38 | ||
| 14-Day ATR (kr) | 1.770716 | ||
| 20-Day SMA (kr) | 6.77975 | ||
| 12-1 Month Momentum % | -87.92 | ||
| 52-Week Range (kr) | 5.7 - 199.8 | ||
| Shares Outstanding (Mil) | 16.91 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Alligator Bioscience AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Alligator Bioscience AB Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Alligator Bioscience AB Frequently Asked Questions
What is Alligator Bioscience AB(LTS:0RK9)'s stock price today?
The current price of LTS:0RK9 is kr6.36. The 52 week high of LTS:0RK9 is kr199.80 and 52 week low is kr5.70.
When is next earnings date of Alligator Bioscience AB(LTS:0RK9)?
The next earnings date of Alligator Bioscience AB(LTS:0RK9) is 2025-04-24.
Does Alligator Bioscience AB(LTS:0RK9) pay dividends? If so, how much?
Alligator Bioscience AB(LTS:0RK9) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers